Funder
royesh venture capital fund
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Regulation, E., No. 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) no 726/2004. Journal of European Union, (324), 121–137.
2. Barnhoorn, M. C., et al. (2020). Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas. Journal of Crohn’s & Colitis, 14(1), 64–70.
3. Khalifeh Soltani, S., et al. (2019). Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: A pilot study. Cytotherapy, 21(1), 54–63.
4. Levy, M. L., et al. (2019). Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke. Stroke, 50(10), 2835–2841.
5. Matthay, M. A., et al. (2019). Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): A randomised phase 2a safety trial. The Lancet Respiratory Medicine, 7(2), 154–162.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献